Page 232 - வெளிப்புறம் வாழ்க்கைத்தொழில்கள் அமைச்சர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Updated: April 21, 2021 13:49 IST Experts said Covishield is being produced at a much higher scale than Covaxin due to which its availability is more. Share Article AAA India granted emergency use authorisation to Covaxin and Covishield, following which the vaccination drive started in the country on January 16.   | Photo Credit: Nagara Gopal Experts said Covishield is being produced at a much higher scale than Covaxin due to which its availability is more. Covishield, from the Oxford/AstraZeneca stable, comprises over 90% of the 12.76 crore COVID-19 vaccines administered across the country so far, according to government data on Wednesday. Of this, 15 States and union territories have only given Covishield, being manufactured by the Pune-based Serum Instiute of India. The other vaccine being administered in India is the indigenous Covaxin from Bharat Biotech in Hyderabad.

Jammu and kashmirAndhra pradeshOxford astrazenecaNarendra modiIndian council of medical researchDepartment of biotechnologyPune based serum instiuteBharat biotechSamiran pandaCommunicable diseasesIndian councilMedical researchMinister narendra modiExternal affairs ministerCoronavirus vaccineCovid 19